Mebeverine Hydrochloride Rudipharm

Mebeverine Hydrochloride, the active ingredient in Mebeverine Hydrochloride Rudipharm, is an antispasmodic presented as an oral dosage form for oral use. It is employed to relieve smooth‑muscle spasm in the gastrointestinal tract, particularly in patients with irritable bowel syndrome and related functional disorders.

GNH USA supplies Mebeverine Hydrochloride Rudipharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mebeverine Hydrochloride is indicated for disorders of gastrointestinal smooth‑muscle activity. It is used in the following conditions: - Irritable bowel syndrome: reduces abdominal pain, cramping and irregular bowel movements. - Functional gastrointestinal disorders: alleviates spasmodic discomfort and improves quality of life. - Spastic colon: helps normalize colonic motility and lessen stool urgency.

Mebeverine Hydrochloride is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Dry mouth: reduced salivation. - Headache: transient cranial discomfort. - Dizziness: occasional light‑headedness. - Abdominal discomfort: mild cramping.

Serious or Rare Side Effects: - Allergic reactions: rash, itching, or swelling. - Angioedema: rapid swelling of face, lips or throat. - Cardiac arrhythmia: rare disturbances in heart rhythm. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic dysfunction: abnormal liver enzymes in rare cases.

Before initiating therapy, clinicians should consider several safety aspects. - Renal function assessment: adjust use in severe renal impairment. - Hepatic monitoring: use cautiously in patients with liver disease. - Allergy history: avoid if known hypersensitivity to mebeverine or excipients. - Concomitant anticholinergics: monitor for additive anticholinergic effects. - Pregnancy and lactation: evaluate risk‑benefit; limited data available. - Store below 25°C: keep in the original pack, protect from moisture.

Mebeverine Hydrochloride may interact with other medicines; awareness of the interaction level is important.

Major Interactions (Avoid): - Other antispasmodics: combined use can increase anticholinergic burden. - Strong CYP3A4 inhibitors: may raise plasma levels, though data are limited.

Moderate Interactions (Monitor Closely): - Antacids: may alter gastric pH and affect absorption. - Other gastrointestinal motility agents: additive effects on gut motility. - Certain antidepressants (e.g., tricyclics): monitor for enhanced anticholinergic symptoms.